Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)
Diabetes · 2024
DOI: 10.2337/db23-0401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Arianne Aslamy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA. Hauptthemen laut MEDLINE: Insulin Resistance, Prediabetic State, Microbiota, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Short-chain fatty acids (SCFAs) have been extensively studied for potential beneficial roles in glucose homeostasis and risk of diabetes; however, most of this research has focused on butyrate, acetate, and propionate. The effect on metabolism of branched SCFAs (BSCFAs; isobutyrate, isovalerate, and methylbutyrate) is largely unknown. In a cohort of 219 non-Hispanic White participants and 126 African American participants, we examined the association of BSCFA with dysglycemia (prediabetes and diabetes) and oral glucose tolerance test–based measures of glucose and insulin homeostasis, as well as with demographic, anthropometric, lifestyle, and lipid traits, and other SCFAs. We observed a bimodal distribution of BSCFAs, with 25 individuals having high levels (H-BSCFA group) and 320 individuals having lower levels (L-BSCFA group). The prevalence of dysglycemia was lower in the H-BSCFA group compared with the L-BSCFA group (16% vs. 49%; P = 0.0014). This association remained significant after adjustment for age, sex, race, BMI, and levels of other SCFAs. Consistent with the lower rate of dysglycemia, fasting and postprandial glucose levels were lower and the disposition index was higher in the H-BSCFA group. Additional findings in H-BSCFA versus L-BSCFA included lower fasting and postprandial C-peptide levels and lower insulin clearance without differences in insulin levels, insulin sensitivity, insulin secretion, or other variables examined, including diet and physical activity. As one of the first human studies associating higher BSCFA levels with lower odds of dysglycemia and improved glucose homeostasis, this study sets the stage for further investigation of BSCFA as a novel target for prevention or treatment of diabetes. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX.
- Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC.
- Metabolon Inc., Morrisville, NC.
- School of Medicine, University of California San Diego, La Jolla, CA.
- Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation and Department of Pediatrics, UCLA Medical Center, Harbor-Torrance, CA.
ORCID-Profile: Mark O Goodarzi
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- USDA/ARS
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Disease
Zitieren
APA
Aslamy, A., Wood, A. C., Jensen, E. T., Bertoni, A. G., Sheridan, P. A., Wong, K. E., Ramesh, G., Rotter, J. I., Chen, Y. I., & Goodarzi, M. O. (2024). Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. https://doi.org/10.2337/db23-0401
Vancouver
Aslamy A, Wood AC, Jensen ET, Bertoni AG, Sheridan PA, Wong KE, et al. Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. 2024. doi:10.2337/db23-0401
BibTeX
@article{Aslamy2024,
author = {Aslamy, Arianne and Wood, Alexis C and Jensen, Elizabeth T and Bertoni, Alain G and Sheridan, Patricia A and Wong, Kari E and Ramesh, Gautam and Rotter, Jerome I and Chen, Yii-Der I and Goodarzi, Mark O},
title = {Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db23-0401}
}
EUVIMED